Year archive

CanSino Biologics Inc. — 2024 filings

All 99 regulatory filings released by CanSino Biologics Inc. (6185) in 2024, sourced directly from the official regulator.

99 Filings

2024 Period

2024 filings (99)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - MENHYCIA OBTAINS DRUG REGISTRATION CERTIFICATE IN INDONESIA Regulatory Filings	2024-12-30	English
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I/II CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE I CLINICAL TRIAL FOR RECOMBINANT POLIOMYELITIS VACCINE IN INDONESIA Regulatory Filings	2024-12-20	English
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE II/III CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL FOR TDCP ADOLESCENT AND ADULT Regulatory Filings	2024-12-20	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-12-20	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-12-20	English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR DTCP INFANT Regulatory Filings	2024-12-16	English
INSIDE INFORMATION - CHANGE OF INTERESTS OF PARTIES ACTING IN CONCERT Major Shareholding Notification	2024-12-13	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-12-04	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2024-12-03	English
VOLUNTARY ANNOUNCEMENT - ANNOUNCEMENT ON THE 2024 INVESTOR OPEN DAY EVENT Regulatory Filings	2024-12-01	English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL DRUG APPLICATION FOR MENHYCIA Regulatory Filings	2024-11-26	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-11-25	English
CHANGE OF EMPLOYEE REPRESENTATIVE SUPERVISOR Board/Management Information	2024-11-25	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-11-15	English
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, FREEZE-DRIED Regulatory Filings	2024-11-15	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2024-11-05	English
THIRD QUARTERLY REPORT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2024 Interim / Quarterly Report 9M 2024	2024-10-29	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-10-16	English
VOLUNTARY ANNOUNCEMENT - GRANT AGREEMENT OF RECOMBINANT POLIOMYELITIS VACCINE AND RELATED COMBINED VACCINE PROJECT Capital/Financing Update	2024-10-09	English
VOLUNTARY ANNOUNCEMENT - RECOMBINANT POLIOMYELITIS VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN INDONESIA Regulatory Filings	2024-10-09	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2024-10-07	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-09-06	English
Interim Report 2024 Interim / Quarterly Report H1 2024	2024-09-06	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2024-09-03	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-08-29	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Regulatory Filings	2024-08-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-08-27	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-08-16	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2024-08-02	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-07-25	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-07-11	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2024-07-05	English
List of Directors and their Roles and Functions Board/Management Information	2024-06-27	English
POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING; AND ELECTION OF NON-EXECUTIVE DIRECTOR OF THIRD SESSION OF BOARD OF DIRECTORS Declaration of Voting Results & Voting Rights Announcements	2024-06-27	English
VOLUNTARY ANNOUNCEMENT - PROPOSED INCREASE IN SHAREHOLDING BY CONTROLLING SHAREHOLDERS AND EXECUTIVE DIRECTORS Major Shareholding Notification	2024-06-21	English
Form of Proxy for use at the 2023 Annual General Meeting to be held on Thursday, June 27, 2024 AGM Information	2024-06-04	English
NOTICE OF 2023 ANNUAL GENERAL MEETING AGM Information	2024-06-04	English
2023 AGM CIRCULAR AGM Information	2024-06-04	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2024-06-04	English
List of Directors and their Roles and Functions Board/Management Information	2024-05-31	English
RESIGNATION OF DIRECTOR AND PROPOSED APPOINTMENT OF DIRECTOR Board/Management Information	2024-05-31	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-05-31	English
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSIT Capital/Financing Update	2024-05-21	English
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSIT Capital/Financing Update	2024-05-08	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2024-05-07	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-30	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-30	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-30	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-29	English
FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED MARCH 31, 2024 Interim / Quarterly Report Q1 2024	2024-04-29	English
2023 Environmental, Social and Governance & Corporate Social Responsibility Report Environmental & Social Information	2024-04-24	English
2023 ANNUAL REPORT Annual Report FY 2023	2024-04-24	English
VOLUNTARY ANNOUNCEMENT - HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, FREEZE-DRIED OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-04-22	English
VOLUNTARY ANNOUNCEMENT - POSITIVE PRELIMINARY PHASE I CLINICAL RESULTS FOR PROTEIN-BASED PNEUMOCOCCAL VACCINE Regulatory Filings	2024-04-21	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-04-17	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-11	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-11	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-11	English
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSIT Capital/Financing Update	2024-04-11	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-04-03	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2024-04-03	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-03-27	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 Annual Report FY 2023	2024-03-27	English
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE III CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR ABSORBED TETANUS VACCINE Regulatory Filings	2024-03-20	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-03-15	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-03-13	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2024-03-01	English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF DRUG REGISTRATION APPLICATION FOR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (CRM197, TT VECTOR) Regulatory Filings	2024-02-28	English
List of Directors and their Roles and Functions Board/Management Information	2024-02-23	English
ELECTIONS RELATING TO BOARD OF DIRECTORS, BOARD COMMITTEES AND BOARD OF SUPERVISORS Board/Management Information	2024-02-23	English
INSIDE INFORMATION UPDATES ON 2023 PRELIMINARY ANNUAL RESULTS Earnings Release FY 2023	2024-02-23	English
ARTICLES OF ASSOCIATION Governance Information	2024-02-21	English
List of Directors and their Roles and Functions Board/Management Information	2024-02-21	English
POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING; AMENDMENTS TO THE ARTICLES OF ASSOCIATION; ELECTION OF DIRECTORS OF THIRD SESSION OF BOARD OF DIRECTORS; RETIREMENT OF DIRE Declaration of Voting Results & Voting Rights Announcements	2024-02-21	English
FURTHER ELABORATION OF CUMULATIVE VOTING SYSTEM TO BE ADOPTED FOR CERTAIN RESOLUTIONS PROPOSED AT THE 2024 FIRST EGM Declaration of Voting Results & Voting Rights Announcements	2024-02-05	English
INSIDE INFORMATION DECONSOLIDATION OF CANSINO SPH BIOLOGICS INC. Regulatory Filings	2024-02-02	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2024-02-02	English
INSIDE INFORMATION RESULTS FORECAST FOR THE YEAR 2023 Regulatory Filings	2024-01-30	English
VOLUNTARY ANNOUNCEMENT - OBTAINING THE FINAL REPORT OF PHASE III CLINICAL TRIAL OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (CRM197, TT VECTOR) Regulatory Filings	2024-01-30	English
2024 FIRST EGM CIRCULAR Proxy Solicitation & Information Statement	2024-01-30	English
Form of Proxy for use at the 2024 First Extraordinary General Meeting to be held on Wednesday, February 21, 2024 Proxy Solicitation & Information Statement	2024-01-30	English
NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING AGM Information	2024-01-30	English
TERMS OF REFERENCE FOR THE REMUNERATION AND ASSESSMENT COMMITTEE OF THE BOARD Remuneration Information	2024-01-19	English
TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE OF THE BOARD Governance Information	2024-01-19	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD Governance Information	2024-01-19	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-01-19	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-01-19	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-01-19	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-01-19	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-01-19	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-01-19	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-01-19	English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RULES OF PROCEDURES; PROPOSED AMENDMENTS TO THE TERMS OF REFERENCE FOR INDEPENDENT NON-EXECUTIVE DIRECTORS; RESIGNATION OF DIRECTOR&#x3 Board/Management Information	2024-01-19	English
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR RECOMBINANT POLIOMYELITIS VACCINE Regulatory Filings	2024-01-15	English
Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Report Publication Announcement	2024-01-11	English
Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Report Publication Announcement	2024-01-11	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2024-01-02	English

Filings by year

2026 28 filings
2025 72 filings
2024 99 filings
2023 153 filings
2022 186 filings
2021 166 filings
2020 101 filings
2019 62 filings
2018 4 filings